Louise J. M. Alferink

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort

Jeroen L.A. van Vugt, Louise J. M. Alferink, Stefan Buettner et al. · Journal of Hepatology · 2017 · 207 citations · Full text

Medicine, Biostatistics, Geriatric Medicine +17

Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study

Louise J. M. Alferink, Jessica C. Kiefte–de Jong, Nicole S. Erler et al. · Gut · 2018 · 133 citations

Public Health, Nutrition, Nutritional Sciences +17

Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution

Louise J. M. Alferink, Katerina Trajanoska, Nicole S. Erler et al. · Journal of Bone and Mineral Research · 2019 · 91 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17

Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study

Laurens A. van Kleef, Ibrahim Ayada, Louise J. M. Alferink et al. · Hepatology · 2021 · 89 citations · Full text

Medicine, Internal Medicine, Epidemiology +16

Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas

Jun Liu, Lies Lahousse, Michel G. Nivard et al. · Nature Medicine · 2020 · 87 citations · Full text

Life Sciences, Microbiology, Pharmacology +14